Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$23.56 - $34.25 $390,554 - $567,762
-16,577 Reduced 4.12%
385,778 $11.9 Million
Q1 2021

May 17, 2021

BUY
$15.25 - $31.13 $289,948 - $591,874
19,013 Added 4.96%
402,355 $10.3 Million
Q4 2020

Feb 16, 2021

SELL
$10.69 - $16.0 $109,027 - $163,184
-10,199 Reduced 2.59%
383,342 $6.13 Million
Q3 2020

Nov 16, 2020

BUY
$10.18 - $17.3 $4.01 Million - $6.81 Million
393,541 New
393,541 $4.8 Million

Others Institutions Holding RNLX

About Renalytix plc


  • Ticker RNLX
  • Exchange OTC
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 37,445,900
  • Market Cap $5.62M
  • Description
  • Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...
More about RNLX
Track This Portfolio

Track Arrow Mark Colorado Holdings LLC Portfolio

Follow Arrow Mark Colorado Holdings LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.